Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

A.L.S. Drug Relyvrio Will Be Taken Off the Market, Its Maker Says

Results of a large clinical trial found the treatment did not work any better than a placebo.

Pam Belluck
Author: Pam Belluck

Written by

Pam Belluck

in

Clinical Trials, Corporations, Drugs (Pharmaceuticals), Suits and Litigation (Civil)
←A Racially Biased Test That Prevented Thousands Of Black People From Receiving Kidney Transplants Is Finally Changing
Reworked Italian Jerseys That Celebrate Soccer Style→

More posts

  • Protesters, leaders push back against DHS over Newark detention facility conditions

  • Goldman and Lander spar hard over Israel

  • Snowflake climbs after Q1 results top expectations, guidance gets a boost

  • Synopsys drops despite better than expected Q2 results, big boost to full-year guidance

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube